BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
cell-cell adhesion
,
Inflammatory disorder
,
Endothelial cell
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Sulfonylurea Receptors
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Explore Curated Studies Results
Literature
Most Relevant Literature
Fresh insight into neonatal diabetes mutations.
Epac2: a sulfonylurea receptor?
Role of the amino-terminal transmembrane domain of sulfonylurea receptor SUR2B for coupling to K(IR)…
Sulfonylurea receptor as a target for molecular imaging of pancreas beta cells with (99m)Tc-DTPA-gli…
The common C49620T polymorphism in the sulfonylurea receptor gene SUR1 (ABCC8) in patients with gest…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety…
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety…
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ